Corporate Accountability

Majority of Justices Appear Skeptical About Aggregate Campaign Contribution Limit

By John Gramlich

…David H. Gans, director of the Human Rights, Civil Rights and Citizenship Program at the progressive Constitutional Accountability Center, said Roberts was clearly focused on the aggregate limits as they pertain to candidates, as opposed to political parties and political action committees.

“He spoke much less about the other parties who are limited by the aggregate limits,” Gans said, suggesting that Roberts might attempt to build support for a ruling that would leave some, but perhaps not all, of the aggregate limits in place.

 

Gans also said it was possible that the Supreme Court’s eventual ruling could spell out constitutional objections to aggregate limits, while inviting Congress to rewrite the law in a way that might meet the justices’ objections…..

More from Corporate Accountability

Corporate Accountability
September 9, 2025

ENFORCEMENT ACTIONS—Fifth Circuit rejects petition challenging OCC authority to enforce national banking rules

Wolters Kluwer VitalLaw
The court distinguished the national banking regulatory regime from the SEC’s antifraud provision in Jarkesy and the...
Corporate Accountability
July 11, 2025

This Group’s Record in Front of the Roberts Court Is Mind-Boggling

Slate
In a provocative dissenting opinion, Justice Ketanji Brown Jackson recently called out her colleagues on the Supreme Court...
By: Ana Builes, Brian R. Frazelle
Corporate Accountability
July 2, 2025

Moneyed Interests Still Prevail at the Supreme Court (2024-2025 Term)

The Court Continues to Favor Corporations over Workers, Consumers, and the Environment.
By: Brian R. Frazelle, Ana Builes
Corporate Accountability
U.S. Court of Appeals for the Third Circuit

Novartis v. Secretary United States Department of Health and Human Services

In Novartis v. Secretary United States Department of Health and Human Services, the United States Court of Appeals for the Third Circuit considered whether the Inflation Reduction Act’s Medicare drug price negotiation program is an unconstitutional...
Corporate Accountability
January 28, 2025

Federal Deposit Insurance as Jarkesy Waiver

Yale Journal on Regulation
An argument lurking just beneath the surface in a pending Fifth Circuit case could stem...
Corporate Accountability
U.S. Court of Appeals for the Second Circuit

Boehringer Ingelheim v. Department of Health and Human Services

In Boehringer Ingelheim v. Department of Health and Human Services, the United States Court of Appeals for the Second Circuit considered whether the Inflation Reduction Act’s Medicare drug price negotiation program is an unconstitutional taking...